- ►sld.cu [PDF] P Malfertheiner, F Megraud, C O'morain, F … - British Medical Journal, 2007 - gut.bmj.com Results: Eradication of H pylori infection is recommended in (a) patients with
gastroduodenal diseases such as peptic ulcer disease and low grade gastric,
mucosa associated lymphoid tissue (MALT) lymphoma; (b) patients with ... Cited by 492 - Related articles - BL Direct - All 7 versions
- ►bmj.com F Megraud - British Medical Journal, 2004 - gut.bmj.com The discovery that Helicobacter pylori infection is the main cause of most
gastroduodenal diseases has been a major breakthrough in gastroenterology. It
has dramatically changed the management of these diseases which are now ... Cited by 172 - Related articles - BL Direct - All 6 versions
RJ Saad, P Schoenfeld, HM Kim, WD Chey - Am J Gastroenterol, 2006 - medicaidprovider.hhs.mt.gov METHODS: A search of PUBMED, EMBASE, EBM Review databases and abstracts from
recent Digestive Disease Week, United European Gastroenterology Week, and
European Helicobacter Study Group conferences was performed. Randomized ... Cited by 85 - Related articles - View as HTML - All 6 versions
WD Chey, BC Wong… - American Journal of Gastroenterology, 2007 - acg.gi.org Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic
infection. Though the prevalence of this infection appears to be decreasing in
many parts of the world, H. pylori remains an important factor linked to ... Cited by 73 - Related articles - View as HTML - BL Direct - All 44 versions
C Bilardi, P Dulbecco, P Zentilin, S Reglioni, … - Clinical Gastroenterology and Hepatology, 2004 - Elsevier Background & Aims: Antibiotic resistance is a major issue in anti–Helicobacter
pylori treatment. This study was aimed at assessing the efficacy of 2 therapies
in patients with resistant H pylori infection. Methods: Patients who had ... Cited by 52 - Related articles - BL Direct - All 13 versions
TW Hennessy, RJ Singleton, LR Bulkow, DL … - Vaccine, 2005 - Elsevier We evaluated invasive pneumococcal disease (IPD), antimicrobial resistance and
nasopharyngeal colonization before and after introduction of pneumococcal
conjugate vaccine (PCV7) in Alaska Natives (AN), a population with high IPD ... Cited by 51 - Related articles - All 5 versions
- ►oxfordjournals.org RS Howell-Jones, MJ Wilson, KE Hill, AJ … - Journal of Antimicrobial Chemotherapy, 2005 - Br Soc Antimicrob Chemo Chronic leg and foot wounds represent an increasing burden to healthcare systems
as the age of the population increases. The deep dermal tissues of all chronic
wounds harbour microorganisms, however, the precise interaction between ... Cited by 39 - Related articles - All 6 versions
JM Zuckerman - Infectious disease clinics of North America, 2004 - Elsevier Erythromycin, the first macrolide antibiotic discovered, has been used since the
early 1950s for the treatment of upper respiratory tract and skin and soft
tissue infections caused by susceptible organisms, especially in the ... Cited by 33 - Related articles - BL Direct - All 6 versions
RM McLoughlin, CA O'Morain, HJ O'Connor - Fundamental & clinical pharmacology, 2005 - pt.wkhealth.com Helicobacter pylori plays a key role in dyspepsia, peptic ulcer disease, and
gastric neoplasia and eradication of the infection has become an important
treatment goal in clinical practice. Seven-day proton-pump ... Cited by 27 - Related articles - BL Direct - All 5 versions
S Nahar, AK Mukhopadhyay, R Khan, MM … - Journal of Clinical Microbiology, 2004 - pubmedcentral.nih.gov Page 1. J OURNAL OF C LINICAL M ICROBIOLOGY , Oct. 2004, p. 4856–4858 Vol.
42, No. 10 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.10 ... Cited by 23 - Related articles - BL Direct - All 7 versions
